95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-1.41%
Negative revenue growth while OR stands at 7.68%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-9.76%
Negative gross profit growth while OR is at 1.05%. Joel Greenblatt would examine cost competitiveness or demand decline.
-6.19%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-6.19%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-5.33%
Negative net income growth while OR stands at 410.35%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-5.71%
Negative EPS growth while OR is at 379.76%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-5.71%
Negative diluted EPS growth while OR is at 379.15%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.14%
Share reduction more than 1.5x OR's 11.02%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.09%
Diluted share reduction more than 1.5x OR's 10.97%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
-1.99%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
15.97%
Positive FCF growth while OR is negative. John Neff would see a strong competitive edge in net cash generation.
17.83%
10Y CAGR of 17.83% while OR is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
48.43%
5Y revenue/share CAGR under 50% of OR's 100.50%. Michael Burry would suspect a significant competitive gap or product weakness.
57.84%
Positive 3Y CAGR while OR is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
-6.51%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
61.94%
Positive OCF/share growth while OR is negative. John Neff might see a comparative advantage in operational cash viability.
86.47%
Positive 3Y OCF/share CAGR while OR is negative. John Neff might see a big short-term edge in operational efficiency.
-17.41%
Negative 10Y net income/share CAGR while OR is at 100.90%. Joel Greenblatt sees a major red flag in long-term profit erosion.
115.73%
Positive 5Y CAGR while OR is negative. John Neff might view this as a strong mid-term relative advantage.
218.03%
3Y net income/share CAGR 50-75% of OR's 319.20%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
76.72%
Equity/share CAGR of 76.72% while OR is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
24.80%
Positive 5Y equity/share CAGR while OR is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
23.93%
3Y equity/share CAGR above 1.5x OR's 2.55%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
44.13%
Dividend/share CAGR of 44.13% while OR is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
119.91%
5Y dividend/share CAGR above 1.5x OR's 42.24%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
82.04%
3Y dividend/share CAGR above 1.5x OR's 8.72%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-46.31%
Firm’s AR is declining while OR shows 35.74%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
61.49%
Inventory growth well above OR's 5.22%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-0.33%
Negative asset growth while OR invests at 1.06%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.92%
Under 50% of OR's 2.57%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-9.45%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-44.46%
We cut SG&A while OR invests at 17.64%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.